Design of the GutHeart—targeting gut microbiota to treat heart failure—trial: a Phase II, randomized clinical trial

AIMS: Heart failure (HF) is a multifactorial disease. Current treatments target only a fraction of the putative pathophysiological pathways. In patients with HF, reduced cardiac output and congestion cause increased gut wall permeability. It has been suggested that leakage of microbial products is d...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:ESC Heart Fail
Egile Nagusiak: Mayerhofer, Cristiane C.K., Awoyemi, Ayodeji O., Moscavitch, Samuel D., Lappegård, Knut Tore, Hov, Johannes R., Aukrust, Pål, Hovland, Anders, Lorenzo, Andrea, Halvorsen, Sigrun, Seljeflot, Ingebjørg, Gullestad, Lars, Trøseid, Marius, Broch, Kaspar
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2018
Gaiak:
Study Designs
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6165929/
https://ncbi.nlm.nih.gov/pubmed/30088346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12332
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak